Kana Taniguchi

725 total citations
12 papers, 590 citations indexed

About

Kana Taniguchi is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Kana Taniguchi has authored 12 papers receiving a total of 590 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 5 papers in Physiology. Recurrent topics in Kana Taniguchi's work include Neuropeptides and Animal Physiology (6 papers), Pain Mechanisms and Treatments (4 papers) and Receptor Mechanisms and Signaling (4 papers). Kana Taniguchi is often cited by papers focused on Neuropeptides and Animal Physiology (6 papers), Pain Mechanisms and Treatments (4 papers) and Receptor Mechanisms and Signaling (4 papers). Kana Taniguchi collaborates with scholars based in Japan and United States. Kana Taniguchi's co-authors include Katsuhiro Shinjo, Atsushi Nagahisa, Akio Murase, Jeffrey L. Stock, Hyungsuk Kim, Patrick J. Flannery, John Burkhardt, Marsha L. Roach, Thomas M. Coffman and Laurent Audoly and has published in prestigious journals such as Journal of Clinical Investigation, Gastroenterology and Pain.

In The Last Decade

Kana Taniguchi

12 papers receiving 569 citations

Peers

Kana Taniguchi
Flora Beiche Germany
J.L. Oskins United States
Sardar Y.K. Yousufzai United States
Beavo Ja United States
Wesley Lebel United States
F. Assimacopoulos Switzerland
Kana Taniguchi
Citations per year, relative to Kana Taniguchi Kana Taniguchi (= 1×) peers Katsuhiro Shinjo

Countries citing papers authored by Kana Taniguchi

Since Specialization
Citations

This map shows the geographic impact of Kana Taniguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kana Taniguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kana Taniguchi more than expected).

Fields of papers citing papers by Kana Taniguchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kana Taniguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kana Taniguchi. The network helps show where Kana Taniguchi may publish in the future.

Co-authorship network of co-authors of Kana Taniguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Kana Taniguchi. A scholar is included among the top collaborators of Kana Taniguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kana Taniguchi. Kana Taniguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Hori, Yoko, Kana Taniguchi, Tadashi Okabe, & Atsuhiro Sakamoto. (2016). A case of unexpectedly difficult intubation caused by a large asymptomatic choanal polyp. JA Clinical Reports. 2(1). 2–2. 3 indexed citations
2.
Iwata, Yasuhiro, et al.. (2014). Identification of a highly potent and selective CB2 agonist, RQ-00202730, for the treatment of irritable bowel syndrome. Bioorganic & Medicinal Chemistry Letters. 25(2). 236–240. 26 indexed citations
3.
Takasaki, Ichiro, Kana Taniguchi, Atsushi Sasaki, et al.. (2011). Contribution of spinal galectin-3 to acute herpetic allodynia in mice. Pain. 153(3). 585–592. 34 indexed citations
4.
Takahashi, Nobuyuki, et al.. (2011). The Novel 5-HT2B Receptor Antagonist, RQ-00310941, Attenuates Visceral Hypersensitivity and Abnormal Defecation in Rat Models. Gastroenterology. 140(5). S–607. 4 indexed citations
5.
Okumura, Takako, Yoko Murata, Kana Taniguchi, Akio Murase, & Aisuke Nii. (2008). Effects of the selective EP4 antagonist, CJ-023,423 on chronic inflammation and bone destruction in rat adjuvant-induced arthritis. Journal of Pharmacy and Pharmacology. 60(6). 723–730. 24 indexed citations
6.
Nakao, Kazunari, Akio Murase, Hiroyuki Ohshiro, et al.. (2007). CJ-023,423, a Novel, Potent and Selective Prostaglandin EP4 Receptor Antagonist with Antihyperalgesic Properties. Journal of Pharmacology and Experimental Therapeutics. 322(2). 686–694. 99 indexed citations
7.
Stock, Jeffrey L., Katsuhiro Shinjo, John Burkhardt, et al.. (2001). The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure. Journal of Clinical Investigation. 107(3). 325–331. 186 indexed citations
8.
Taniguchi, Kana, Katsuhiro Shinjo, Mayumi Mizutani, et al.. (1997). Antinociceptive activity of CP‐101,606, an NMDA receptor NR2B subunit antagonist. British Journal of Pharmacology. 122(5). 809–812. 109 indexed citations
9.
Nagahisa, Atsushi, Yoshihito Kanai, Osamu Suga, et al.. (1993). Antiinflammatory and analgesic activity of CP-96,345: on orally active non-peptide substance P receptor antagonist. Regulatory Peptides. 46(1-2). 440–443. 3 indexed citations
10.
Nagahisa, Atsushi, et al.. (1993). Non-specific activity of in models of pain and inflammation. Regulatory Peptides. 46(1-2). 433–436. 3 indexed citations
11.
Nagahisa, Atsushi, Yoshihito Kanai, Osamu Suga, et al.. (1992). Antiinflammatory and analgesic activity of a non-peptide substance P receptor antagonist. European Journal of Pharmacology. 217(2-3). 191–195. 51 indexed citations
12.
Nagahisa, Atsushi, et al.. (1992). Non‐specific activity of (±)‐CP‐96,345 in models of pain and inflammation. British Journal of Pharmacology. 107(2). 273–275. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026